Las publicaciones del grupo de los últimos años son las siguientes:
1. López, D. 2022. Prediction of Conserved HLA Class I and Class II Epitopes from SARS-CoV-2 Licensed Vaccines Supports T-Cell Cross-Protection against SARS-CoV-1. Biomedicines. 10.
2. Tajuelo, A., M. López-Siles, V. Mas, P. Perez-Romero, J. M. Aguado, V. Briz, M. J. McConnell, A. J. Martín-Galiano, and D. López. 2022. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. Int.J.Mol.Sci. 23.
3. López, D. 2022. Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern. Front Immunol. 13:832889.
4. Foix, A., D. López, F. Diez-Fuertes, M. J. McConnell, and A. J. Martín-Galiano. 2022. Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2. PLoS.Comput.Biol. 18:e1009726.
5. Lorente, E., A. J. Martín-Galiano, D. M. Kadosh, A. Barriga, J. Garcia-Arriaza, C. Mir, M. Esteban, A. Admon, and D. López. 2022. Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome. J.Proteome.Res. 21:164-171.
6. Martín-Galiano, A. J., F. Diez-Fuertes, M. J. McConnell, and D. López. 2021. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern. Front Immunol. 12:732693.
7. Alves da, C. T., J. N. Peterson, J. Lang, J. Shulman, X. Liang, B. M. Freed, S. A. Boackle, P. Lauzurica, R. M. Torres, and R. Pelanda. 2021. Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-mice. Proc.Natl.Acad.Sci.U.S.A 118.
8. Lorente, E., M. Marcilla, P. G. de la Sota, A. Quijada-Freire, C. Mir, and D. López. 2021. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry. Int.J.Mol.Sci. 22.
9. de la Sota, P. G., E. Lorente, L. Notario, C. Mir, O. Zaragoza, and D. López. 2021. Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus. Biomedicines. 9.
10. Garcia-Arriaza, J., M. Esteban, and D. López. 2021. Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus. Biomedicines. 9.
11. Corral-Lugo, A., M. López-Siles, D. López, M. J. McConnell, and A. J. Martín-Galiano. 2020. Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development. Vaccines.(Basel) 8.
12. Redondo-Anton, J., M. G. Fontela, L. Notario, R. Torres-Ruiz, S. Rodriguez-Perales, E. Lorente, and P. Lauzurica. 2020. Functional Characterization of a Dual Enhancer/Promoter Regulatory Element Leading Human CD69 Expression. Front Genet. 11:552949.
13. Marquez, A., M. Gomez-Fontela, S. Lauzurica, R. Candorcio-Simon, D. Munoz-Martín, M. Morales, M. Ubago, C. Toledo, P. Lauzurica, and C. Molpeceres. 2020. Fluorescence enhanced BA-LIFT for single cell detection and isolation. Biofabrication. 12:025019.
14. Lorente, E., M. G. Fontela, E. Barnea, A. J. Martín-Galiano, C. Mir, B. Galocha, A. Admon, P. Lauzurica, and D. López. 2020. Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2). Mol.Cell Proteomics. 19:994-1004.
15. Lorente, E., E. Barnea, C. Mir, A. Admon, and D. López. 2020. The HLA-DP peptide repertoire from human respiratory syncytial virus is focused on major structural proteins with the exception of the viral polymerase. J Proteomics. 221:103759.
16. Lorente, E., C. Palomo, E. Barnea, C. Mir, V. M. Del, A. Admon, and D. López. 2019a. Natural Spleen Cell Ligandome in Transporter Antigen Processing-Deficient Mice. J.Proteome.Res. 18:3512-3520.
17. Lorente, E., J. Redondo-Anton, A. Martín-Esteban, P. Guasp, E. Barnea, P. Lauzurica, A. Admon, and J. A. López de Castro. 2019. Substantial Influence of ERAP2 on the HLA-B*40:02 Peptidome: Implications for HLA-B*27-Negative Ankylosing Spondylitis. Mol.Cell Proteomics. 18:2298-2309.
18. Guasp, P., E. Lorente, A. Martín-Esteban, E. Barnea, P. Romania, D. Fruci, J. J. W. Kuiper, A. Admon, and J. A. López de Castro. 2019. Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-Associated HLA-B*51 Peptidome. Mol.Cell Proteomics.
19. Fontela, M. G., L. Notario, E. Alari-Pahissa, E. Lorente, and P. Lauzurica. 2019. The Conserved Non-Coding Sequence 2 (CNS2) Enhances CD69 Transcription through Cooperation between the Transcription Factors Oct1 and RUNX1. Genes (Basel) 10.
20. Brait, V. H., F. Miro-Mur, I. Perez-de-Puig, L. Notario, B. Hurtado, J. Pedragosa, M. Gallizioli, F. Jimenez-Altayo, M. Arbaizar-Rovirosa, A. Otxoa-de-Amezaga, J. Monteagudo, M. Ferrer-Ferrer, l. R. de, X, E. Bonfill-Teixidor, A. Salas-Perdomo, A. Hernandez-Vidal, P. Garcia-de-Frutos, P. Lauzurica, and A. M. Planas. 2019. CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation. Circ.Res. 124:279-291.
21. Notario, L., J. Redondo-Anton, E. Alari-Pahissa, A. Albentosa, M. Leiva, D. López, G. Sabio, and P. Lauzurica. 2019. CD69 Targeting Enhances Anti-vaccinia Virus Immunity. J.Virol. 93.
22. Montes-Casado, M., G. Ojeda, L. Aragoneses-Fenoll, D. López, A. B. de, M. L. Gaspar, U. Dianzani, J. M. Rojo, and P. Portoles. 2019. ICOS deficiency hampers the homeostasis, development and function of NK cells. PLoS.ONE. 14:e0219449.
23. Lorente, E., A. Barriga, E. Barnea, C. Palomo, J. Garcia-Arriaza, C. Mir, M. Esteban, A. Admon, and D. López. 2019. Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence. PLoS.Negl.Trop.Dis. 13:e0007547.
24. López, D., A. Barriga, E. Lorente, and C. Mir. 2019. Immunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design. J.Clin.Med. 8.
25. Lorente, E., A. J. Martín-Galiano, E. Barnea, A. Barriga, C. Palomo, J. Garcia-Arriaza, C. Mir, P. Lauzurica, M. Esteban, A. Admon, and D. López. 2019b. Proteomics analysis reveals that structural proteins of the virion core and involved in gene expression are the main source for HLA class II ligands in vaccinia virus-infected cells. J.Proteome.Res. 18:900-911.
26. Martín-Galiano, A. J. and D. López. 2019. Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells. PLoS.ONE. 14:e0210583.
27. Notario, L., E. Alari-Pahissa, A. Albentosa, M. Leiva, G. Sabio, and P. Lauzurica. 2018. Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR. Leukemia 32:1445-1457.
28. Lorente, E., A. Barriga, J. Garcia-Arriaza, F. A. Lemonnier, M. Esteban, and D. López. 2017. Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein. PLoS.Negl.Trop.Dis. 11:e0006036.
29. Lorente, E., A. Barriga, E. Barnea, C. Mir, J. A. Gebe, A. Admon, and D. López. 2016. Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus. Mol.Cell Proteomics. 15:2141-2151.
30. Notario, L., E. Alari-Pahissa, M. A. de, and P. Lauzurica. 2016. CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis. J.Virol. 90:6464-6474.
31. Johnstone, C., E. Lorente, A. Barriga, E. Barnea, S. Infantes, F. A. Lemonnier, C. S. David, A. Admon, and D. López. 2015. The Viral Transcription Group Determines the HLA Class I Cellular Immune Response Against Human Respiratory Syncytial Virus. Mol.Cell Proteomics. 14:893-904.
32. Laguna, T., L. Notario, R. Pippa, M. G. Fontela, B. N. Vazquez, M. Maicas, N. Aguilera-Montilla, A. L. Corbi, M. D. Odero, and P. Lauzurica. 2015. New insights on the transcriptional regulation of CD69 gene through a potent enhancer located in the conserved non-coding sequence 2. Mol.Immunol. 66:171-179.
33. Barriga, A., E. Lorente, C. Johnstone, C. Mir, M. Del Val, and D. López. 2014. A common minimal motif for the ligands of HLA-B*27 class I molecules. PLoS.ONE. 9:e106772.
34. Nitschke, K., A. Barriga, J. Schmidt, J. Timm, S. Viazov, T. Kuntzen, A. Y. Kim, G. M. Lauer, T. M. Allen, S. Gaudieri, A. Rauch, C. M. Lange, C. Sarrazin, T. Eiermann, J. Sidney, A. Sette, R. Thimme, D. López, and C. Neumann-Haefelin. 2014. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. J.Hepatol. 60:22-29.
35. Lorente, E., A. Barriga, C. Johnstone, C. Mir, M. Jiménez, and D. López. 2013. Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases. PloS One 8:e79596.
36. López, D., E. Lorente, A. Barriga, C. Johnstone, and C. Mir. 2013. Vaccination and the TAP-independent antigen processing pathways. Expert.Rev.Vaccines. 12:1077-1083.
37. Iborra, S., M. Ramos, D. M. Arana, S. Lázaro, F. Aguilar, E. Santos, D. López, E. Fernández-Malavé, and M. Del Val. 2013. N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation. J.Exp.Med. 210:1463-1479.
38. Infantes, S., E. Lorente, E. Barnea, I. Beer, A. Barriga, F. Lasala, M. Jimenez, A. Admon, and D. López. 2013. Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy. J.Biol.Chem. 288:10882-10889.
39. Mackay, L. K., A. Rahimpour, J. Z. Ma, N. Collins, A. T. Stock, M. L. Hafon, J. Vega-Ramos, P. Lauzurica, S. N. Mueller, T. Stefanovic, D. C. Tscharke, W. R. Heath, M. Inouye, F. R. Carbone, and T. Gebhardt. 2013. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat.Immunol. 14:1294-1301.
40. Lorente, E., S. Infantes, E. Barnea, I. Beer, A. Barriga, N. Garcia-Medel, F. Lasala, M. Jimenez, A. Admon, and D. López. 2013. Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells. PLoS.ONE. 8:e59118.